GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Medizen Humancare Inc Co Ltd (XKRX:236340) » Definitions » EV-to-EBITDA

Medizen Humancare Co (XKRX:236340) EV-to-EBITDA : -10.94 (As of Jun. 25, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Medizen Humancare Co EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Medizen Humancare Co's enterprise value is ₩13,925 Mil. Medizen Humancare Co's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was ₩-1,273 Mil. Therefore, Medizen Humancare Co's EV-to-EBITDA for today is -10.94.

The historical rank and industry rank for Medizen Humancare Co's EV-to-EBITDA or its related term are showing as below:

XKRX:236340' s EV-to-EBITDA Range Over the Past 10 Years
Min: -66.65   Med: -10.55   Max: -3.11
Current: -10.94

During the past 7 years, the highest EV-to-EBITDA of Medizen Humancare Co was -3.11. The lowest was -66.65. And the median was -10.55.

XKRX:236340's EV-to-EBITDA is ranked worse than
100% of 110 companies
in the Medical Diagnostics & Research industry
Industry Median: 14.605 vs XKRX:236340: -10.94

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-25), Medizen Humancare Co's stock price is ₩4495.00. Medizen Humancare Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was ₩-606.000. Therefore, Medizen Humancare Co's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Medizen Humancare Co EV-to-EBITDA Historical Data

The historical data trend for Medizen Humancare Co's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medizen Humancare Co EV-to-EBITDA Chart

Medizen Humancare Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial -10.28 -5.58 -10.97 -8.86 -9.77

Medizen Humancare Co Semi-Annual Data
Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA Get a 7-Day Free Trial -10.28 -5.58 -10.97 -8.86 -9.77

Competitive Comparison of Medizen Humancare Co's EV-to-EBITDA

For the Diagnostics & Research subindustry, Medizen Humancare Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medizen Humancare Co's EV-to-EBITDA Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Medizen Humancare Co's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Medizen Humancare Co's EV-to-EBITDA falls into.



Medizen Humancare Co EV-to-EBITDA Calculation

Medizen Humancare Co's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=13925.136/-1273.011
=-10.94

Medizen Humancare Co's current Enterprise Value is ₩13,925 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Medizen Humancare Co's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was ₩-1,273 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medizen Humancare Co  (XKRX:236340) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Medizen Humancare Co's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=4495.00/-606.000
=At Loss

Medizen Humancare Co's share price for today is ₩4495.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Medizen Humancare Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was ₩-606.000.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Medizen Humancare Co EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Medizen Humancare Co's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Medizen Humancare Co (XKRX:236340) Business Description

Traded in Other Exchanges
N/A
Address
Republic of Korea 223, Teheran-ro, Gangnam-gu, Seoul, KOR
Medizen Humancare Inc Co Ltd is a R&D company providing genomics involving acquisition of disease specific genome contents, identification of new drug candidate genes and development of new preventive measures.

Medizen Humancare Co (XKRX:236340) Headlines

No Headlines